Oncology & Cancer

Clinical trials for cancer, one patient at a time

Columbia University Medical Center (CUMC) researchers are developing a new approach to cancer clinical trials, in which therapies are designed and tested one patient at a time. The patient's tumor is "reverse engineered" ...

Oncology & Cancer

Team develops technology to find optimum drug target for cancer

A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the optimum drug targets for specific types of cancer cells. The team used systems biology ...

Neuroscience

Close or far, how smell tells us it's popcorn

People know a smell is popcorn whether it is cooking down the hallway or held right under their noses. Yale researchers Douglas Storace and Lawrence Cohen in the Department of Cellular and Molecular Physiology have found ...

Oncology & Cancer

Newly discovered microRNA regulates mobility of tumor cells

Cancer cells can reactivate a cellular process that is an essential part of embryonic development. This allows them to leave the primary tumor, penetrate the surrounding tissue and form metastases in peripheral organs. In ...

Neuroscience

Perfect balance: How the brain fine-tunes its sensitivity

A sensitive perception of the environment is crucial for guiding our behavior. However, an overly sensitive response of the brain's neural circuits to stimuli can lead to neurodevelopmental disorders such as epilepsy. University ...

Genetics

Cause of cystic kidneys explained

Sylvia Hoff, a graduate student from the Spemann Graduate School of Biology and Medicine (SGBM), has identified a new gene that causes cystic kidneys in children and young adults. The work by the PhD student Sylvia Hoff and ...

page 4 from 5